[go: up one dir, main page]

DK1093369T3 - Middel med antidepressiv virkning indeholdende pramipexol og sertralin - Google Patents

Middel med antidepressiv virkning indeholdende pramipexol og sertralin

Info

Publication number
DK1093369T3
DK1093369T3 DK99934560T DK99934560T DK1093369T3 DK 1093369 T3 DK1093369 T3 DK 1093369T3 DK 99934560 T DK99934560 T DK 99934560T DK 99934560 T DK99934560 T DK 99934560T DK 1093369 T3 DK1093369 T3 DK 1093369T3
Authority
DK
Denmark
Prior art keywords
sertraline
containing pramipexole
antidepressant containing
antidepressant
pramipexole
Prior art date
Application number
DK99934560T
Other languages
Danish (da)
English (en)
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1093369T3 publication Critical patent/DK1093369T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99934560T 1998-07-07 1999-07-02 Middel med antidepressiv virkning indeholdende pramipexol og sertralin DK1093369T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (1)

Publication Number Publication Date
DK1093369T3 true DK1093369T3 (da) 2002-12-16

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934560T DK1093369T3 (da) 1998-07-07 1999-07-02 Middel med antidepressiv virkning indeholdende pramipexol og sertralin

Country Status (32)

Country Link
US (1) US6255329B1 (es)
EP (1) EP1093369B1 (es)
JP (1) JP2002520273A (es)
KR (1) KR100557692B1 (es)
CN (1) CN1230168C (es)
AR (1) AR019896A1 (es)
AT (1) ATE228365T1 (es)
AU (1) AU762128B2 (es)
BG (1) BG64972B1 (es)
BR (1) BR9911768A (es)
CA (1) CA2336833C (es)
CZ (1) CZ294087B6 (es)
DE (2) DE19830201A1 (es)
DK (1) DK1093369T3 (es)
EA (1) EA003142B1 (es)
EE (1) EE04296B1 (es)
ES (1) ES2183583T3 (es)
HU (1) HUP0103922A3 (es)
ID (1) ID27776A (es)
IL (1) IL140603A0 (es)
MY (1) MY117969A (es)
NO (1) NO20010064L (es)
NZ (1) NZ509729A (es)
PL (1) PL195043B1 (es)
PT (1) PT1093369E (es)
RS (1) RS49795B (es)
SK (1) SK284923B6 (es)
TR (1) TR200100146T2 (es)
TW (1) TW592698B (es)
WO (1) WO2000002542A2 (es)
YU (1) YU401A (es)
ZA (1) ZA200100090B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
AU2002360600B2 (en) * 2001-12-11 2007-11-29 University Of Virginia Patent Foundation Use of pramipexole to treat amyotrophic lateral sclerosis
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
DE602006009670D1 (de) * 2005-08-15 2009-11-19 Univ Virginia Neurorestauration mit r(+) pramipexol
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
ES2379117T3 (es) 2006-05-16 2012-04-20 Knopp Neurosciences, Inc. Composiciones de R(+) y S(-) pramipexol y métodos de utilización de las mismas
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
WO2008113056A2 (en) 2007-03-14 2008-09-18 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
CN102186350A (zh) * 2008-08-19 2011-09-14 诺普神经科学股份有限公司 使用(r)-普拉克索的组合物与方法
CA2735934C (en) 2008-09-05 2014-01-07 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
MX2011011579A (es) * 2009-04-30 2012-01-27 Supernus Pharmaceuticals Inc Metodo de tratamiento contra la depresion.
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
AU2013217013B2 (en) 2012-02-08 2017-04-20 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
SMT202100119T1 (it) 2013-07-12 2021-05-07 Knopp Biosciences Llc Trattamento dei livelli elevati di eosinofili e/o basofili
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
EP3038467B1 (en) 2013-08-13 2020-07-29 Knopp Biosciences LLC Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
AU2014306597B2 (en) 2013-08-13 2018-05-17 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
EA202090180A1 (ru) 2017-06-30 2020-05-26 Чейс Терапьютикс Корпорейшн Композиции nk1-антагониста и способы лечения депрессии
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
DE69733996T2 (de) * 1996-03-29 2006-07-20 Pfizer Inc. Benkyl(idene)-lactam-derivate, deren herstellung und verwendung als selektive (ant)agonisten von 5-ht1a- und/oder 5-ht1d rezeptoren
JP2001507678A (ja) * 1996-12-02 2001-06-12 メルク シヤープ エンド ドーム リミテツド 運動障害の治療のためのnk−1受容体拮抗薬の使用
JP4562911B2 (ja) * 1998-01-13 2010-10-13 シンクロニュ−ロン,エルエルシ− 遅発性ジスキネジア及び他の運動障害の治療方法

Also Published As

Publication number Publication date
SK112001A3 (en) 2001-10-08
EE200100014A (et) 2002-06-17
EE04296B1 (et) 2004-06-15
TR200100146T2 (tr) 2001-07-23
ZA200100090B (en) 2002-04-04
MY117969A (en) 2004-08-30
EA003142B1 (ru) 2003-02-27
SK284923B6 (sk) 2006-02-02
HK1037976A1 (en) 2002-03-01
EA200100084A1 (ru) 2001-08-27
WO2000002542A3 (de) 2000-06-22
BG105112A (bg) 2001-10-31
BR9911768A (pt) 2001-04-03
AU5030399A (en) 2000-02-01
RS49795B (sr) 2008-06-05
AU762128B2 (en) 2003-06-19
IL140603A0 (en) 2002-02-10
EP1093369A2 (de) 2001-04-25
HUP0103922A2 (hu) 2002-03-28
ATE228365T1 (de) 2002-12-15
PL195043B1 (pl) 2007-08-31
PL345842A1 (en) 2002-01-14
PT1093369E (pt) 2003-03-31
DE59903556D1 (de) 2003-01-09
DE19830201A1 (de) 2000-01-13
CZ200177A3 (en) 2001-06-13
CN1230168C (zh) 2005-12-07
CA2336833C (en) 2008-09-23
NZ509729A (en) 2003-06-30
AR019896A1 (es) 2002-03-20
NO20010064D0 (no) 2001-01-05
CN1308533A (zh) 2001-08-15
JP2002520273A (ja) 2002-07-09
HUP0103922A3 (en) 2002-08-28
BG64972B1 (bg) 2006-11-30
NO20010064L (no) 2001-03-02
WO2000002542A2 (de) 2000-01-20
ID27776A (id) 2001-04-26
CZ294087B6 (cs) 2004-10-13
TW592698B (en) 2004-06-21
EP1093369B1 (de) 2002-11-27
KR20010079491A (ko) 2001-08-22
CA2336833A1 (en) 2000-01-20
KR100557692B1 (ko) 2006-03-07
YU401A (sh) 2003-10-31
ES2183583T3 (es) 2003-03-16
US6255329B1 (en) 2001-07-03

Similar Documents

Publication Publication Date Title
DK1093369T3 (da) Middel med antidepressiv virkning indeholdende pramipexol og sertralin
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DK0996444T3 (da) Behandling af diabetes med thiazolidindion og metformin
NO20032753L (no) Forbindelse og anvendelse derav
NO20006062L (no) Innkapslede brytere, blandinger og fremgangsmåte for anvendelse derav
NO20022334L (no) Ny sammensetning og anvendelse
DK1224297T3 (da) Alzheimers sygdom -sekretase, APP-substrater derfor og anvendelser deraf
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DE69913128D1 (de) Teilweise blockverschachtelte cdma-kodierung und dekodierung
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
DE59905437D1 (de) Toner und/oder Toner-Mischungen
NO20003916D0 (no) Benzotiadiazoler og derivater
NO20005173D0 (no) Gen som koder for heliomicin og anvendelse derav
NO20003601D0 (no) Nye naftyl-substituerte og anilid-substituerte sulfonamider
DE69904279D1 (de) Aromatisches Polycarbodiimid und Polycarbodiimidfolie
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20021612D0 (no) Karbonylstressreduserende middel
DE60023918D1 (de) MODIFIZIERTE CDNA DES bcl-x GENS DER RATTE UND MODIFIZIERTES PROTEIN
DE60041158D1 (de) Fixier- und/oder Zwischenübertragungstrommel
PT1140994E (pt) Proteinas da superficie externa, suas genes e sua utilizacao
DK1102543T3 (da) Cariesbekæmpende mælkeprodukt og anvendelse deraf
SI1093369T1 (sl) Sredstvo z antidepresivnim učinkom, ki obsega pramipeksol in sertralin
NO20005909D0 (no) Soppbasert middel samt fremstilling og anvendelse av dette